Dystrophin-EV

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameDystrophin-EV
Drug Alias NameSPOT-mRNA03
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionDystroglycan modulators
TargetsDystroglycan
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHaining Sipo Biotechnology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Siponuoyin Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A